Kombinationstherapie Mit Checkpoint-Inhibitor

Uro-News
doi 10.1007/s00092-017-1554-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Kombinationstherapie Für Pädiatrische Patienten Mit Vitiligo Ist Effektiv

pädiatrie: Kinder- und Jugendmedizin hautnah
2016English

Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
2020English

Immune Checkpoint Inhibitor Nephrotoxicity: Update 2020

Kidney360
2020English

Checkpoint Inhibitor–TKI Combos Effective in RCC

Cancer Discovery
Oncology
2019English

PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis

Case Reports in Oncology
Oncology
2017English

A Case of Checkpoint Inhibitor-Induced Celiac Disease

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Webinar | Humanized Mouse Models in Checkpoint Inhibitor Development

Science
MultidisciplinaryPhilosophy of ScienceHistory
2017English

T-Cell Lymphoma Secondary to Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Development of PARP and Immune-Checkpoint Inhibitor Combinations

Cancer Research
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy